Profil
William Edge is an Investment Consultant of NVM.
Mr. Edge is a Director of the Merlin Fund and the Merlin Biosciences Fund.
He served as a Director of Alizyme Plc until April 1, 2009.
Ehemalige bekannte Positionen von William Edge
| Unternehmen | Position | Ende |
|---|---|---|
Alizyme Plc
 Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 01.04.2009 |
NVM Private Equity LLP
 NVM Private Equity LLP Investment ManagersFinance NVM Private Equity LLP(NVM Private Equity) is a independent private equity firm founded in 1984. The firm is headquartered in London, the United Kingdom. | Mitglied des Investmentausschusses | 30.06.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
NVM Private Equity LLP
NVM Private Equity LLP Investment ManagersFinance NVM Private Equity LLP(NVM Private Equity) is a independent private equity firm founded in 1984. The firm is headquartered in London, the United Kingdom. | Finance |
Alizyme Plc
Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
